| editorial | Q871232 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(78)92162-1 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673678921621?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673678921621?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 82146 |
| P2860 | cites work | Journal of Infectious Diseases | Q4051141 |
| Group Y meningococcal disease in united states air force recruits | Q41256729 | ||
| Prevention of secondary cases of meningococcal disease in household contacts by vaccination | Q50715234 | ||
| Group A Meningococcal Polysaccharide Vaccine and Course of the Group A Meningococcal Epidemic in Finland | Q67312787 | ||
| Clinical Efficacy of Meningococcus Group A Capsular Polysaccharide Vaccine in Children Three Months to Five Years of Age | Q34201570 | ||
| Prevention of Meningococcal Disease by Group C Polysaccharide Vaccine | Q34225615 | ||
| Duration of antibody responses after vaccination with group C Neisseria meningitidis polysaccharide | Q34331670 | ||
| Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants | Q35901911 | ||
| Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers | Q36269725 | ||
| Is group-specific meningococcal vaccination resulting in epidemics caused by groups of virulent meningococci? | Q39502560 | ||
| P433 | issue | 8101 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1185-1186 | |
| P577 | publication date | 1978-12-01 | |
| 1978-12-02 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Who should be given meningococcal vaccine? | |
| Who Should be Given Meningococcal Vaccine? | |||
| P478 | volume | 2 |
Search more.